| scholarly article | Q13442814 |
| P2093 | author name string | Tsutsui S | |
| Nomura T | |||
| Miyazaki T | |||
| Sugiyama S | |||
| Niwa T | |||
| Tsukushi S | |||
| P304 | page(s) | S23-8 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Kidney International. Supplement | Q26842696 |
| P1476 | title | The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients | |
| P478 | volume | 62 |
| Q36770933 | A Randomized, Controlled Trial of Oral Intestinal Sorbent AST-120 on Renal Function Deterioration in Patients with Advanced Renal Dysfunction |
| Q37523477 | AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled study |
| Q37549208 | AST-120 for the management of progression of chronic kidney disease |
| Q35530569 | Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD. |
| Q42384012 | Back to the future: restricted protein intake for conservative management of CKD, triple goals of renoprotection, uremia mitigation, and nutritional health |
| Q41907635 | Binding affinity and capacity for the uremic toxin indoxyl sulfate |
| Q79448772 | Carbonic-adsorbent AST-120 reduces overload of indoxyl sulfate and the plasma level of TGF-beta1 in patients with chronic renal failure |
| Q31076633 | Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate |
| Q38001210 | Considerations in the optimal preparation of patients for dialysis |
| Q51732046 | Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease. |
| Q46598361 | Crucial Role of the Aryl Hydrocarbon Receptor (AhR) in Indoxyl Sulfate-Induced Vascular Inflammation |
| Q35411236 | Dietary fiber effects in chronic kidney disease: a systematic review and meta-analysis of controlled feeding trials |
| Q46450675 | Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in vivo renal uptake of uremic toxins in rats |
| Q39199791 | Effect of AST-120 on Endothelial Dysfunction in Adenine-Induced Uremic Rats. |
| Q35219453 | Functional genomic analysis identifies indoxyl sulfate as a major, poorly dialyzable uremic toxin in end-stage renal disease |
| Q50077620 | Gut microbiota in cardiovascular disease and heart failure |
| Q42025309 | Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate |
| Q58749760 | Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120 |
| Q39125093 | Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease. |
| Q33780032 | Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD). |
| Q35116379 | Indoxyl sulfate downregulates expression of Mas receptor via OAT3/AhR/Stat3 pathway in proximal tubular cells |
| Q34621513 | Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-κB. |
| Q35364712 | Indoxyl sulfate-induced activation of (pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells |
| Q48264422 | Involvement of indoxyl sulfate in renal and central nervous system toxicities during cisplatin-induced acute renal failure |
| Q34728267 | Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies |
| Q41025409 | Long-term effects of AST-120 on the progression and prognosis of pre-dialysis chronic kidney disease: a 5-year retrospective study |
| Q26859689 | Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy |
| Q41688602 | Microvesicles Derived from Indoxyl Sulfate Treated Endothelial Cells Induce Endothelial Progenitor Cells Dysfunction. |
| Q64885085 | Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β2-microglobulin-related amyloidosis and indoxyl sulfate-induced atherosclerosis-Oshima Award Address 2016. |
| Q37598894 | Optimization of Bone Health in Children before and after Renal Transplantation: Current Perspectives and Future Directions |
| Q35113743 | Oral adsorbent AST-120 decreases serum levels of AGEs in patients with chronic renal failure |
| Q44609801 | Protein restriction and AST-120 improve lipoprotein lipase and VLDL receptor in focal glomerulosclerosis |
| Q37246931 | Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD. |
| Q61798093 | Review of the efficacy of AST-120 (KREMEZIN) on renal function in chronic kidney disease patients |
| Q92309614 | Role of Resveratrol on Indoxyl Sulfate-Induced Endothelial Hyperpermeability via Aryl Hydrocarbon Receptor (AHR)/Src-Dependent Pathway |
| Q34454655 | Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease |
| Q33890104 | SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial |
| Q37378435 | Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients |
| Q37674146 | Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea |
| Q97518452 | The Effects of Nutrition on the Gastrointestinal Microbiome of Cats and Dogs: Impact on Health and Disease |
| Q88575378 | The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus |
| Q35042986 | The gut microbiome, kidney disease, and targeted interventions |
| Q39009765 | The gut-kidney axis |
| Q35544680 | The microbiome of the urinary tract--a role beyond infection |
| Q33919866 | Timing of dialysis initiation in transplant-naive and failed transplant patients |
| Q40754117 | Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake |
| Q36406668 | Uremic toxin and bone metabolism |
| Q33560454 | p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients |
| Q34593224 | p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease |
| Q84090882 | p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease |
Search more.